CLiX unlock enterprise

Rapidly identify patient cohorts and unique signals in a matter of hours with CLiX® unlock enterprise.

Pharmaceutical organisations are utilising the power of CLiX unlock enterprise to drastically reduce the task of feasibility work and pre-screening, quickly locating specific cohorts within large patient populations.  Marketing and research groups are using CLiX unlock enterprise to rapidly find the unique signals in the narrative text that support their stratification and research efforts. 

Both benefit by finding candidates or data faster, especially in complex therapeutic areas, such as oncology and rare diseases.  

Why use CLiX unlock enterprise?

clinithink_additionalicon_stopwatch_nodots-1

Rapidly interrogate data

Reduce the elapsed time and effort needed to analyse clinical data

clinithink_additionalicon_microscope_nodots-1

Identify the critical signals

Pin-point the granular clinical signals to understand your market or drive clinical research requirements
clinithink_brandicon_barchart_3dots-1

Optimise resource efficiencies

Minimise manual chart review, reallocate clinical resource

ClixUnlock_Enterprise

Key features & benefits

2arrow
Key Feature:

Extract computable features from clinical narrative documents fast and at scale. 

2arrow
Benefit:

Obtain very detailed insights from real world clinical data that cannot be gained from structured coded data. 

2arrow
Key Feature:

Display features in a patient list with drill down into document review.

2arrow
Benefit:

Quickly find the patients most appropriate for a clinical trial and validate the accuracy of the decisions. 

2arrow
Key Feature:

Project model with user access control. 

2arrow
Benefit:

Allows teams access to the data they need while protecting the privacy of patients.

What CLiX® unlock enterprise users say...

“Addressing healthcare ecosystem challenges to enable earlier detection and diagnosis of cancer is one of our UK oncology missions. Focusing specifically on early detection of lung cancer, our partnership with Clinithink is a great example within AstraZeneca Oncology of an external partnership with the common goal of improving UK cancer outcomes.” 
Dr. Satoshi Hori
Oncology Medical Affairs Head at AstraZeneca Oncology UK
AstraZeneca_Logo_Lowres

Ready to talk?

Contact one of our specialists today.